Menarini Stemline at ISLB 2026
Nov 7–9, 2026 Madrid, Spain ~700 attendees Website
Menarini Stemline brings 1 presentation to ISLB 2026 in Madrid. Its work centres on ESR1 mutation testing in liquid biopsy, from lab quality to treatment decisions. It looks at when ESR1 results drive the choice of treatment and what clinicians need from the testing lab.
| Organization | ISLB 2026 Attendance |
|---|---|
Menarini Stemline New York, NY | ◆Diamond Sponsor |
Menarini Group oncology company marketing elacestrant for ESR1-mutated, ER-positive, HER2-negative advanced breast cancer. | Industry Sun Nov 8 12:15pm–1:15pm |
Instantly find 20 buyers from Menarini Stemline
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction